| Title: | Optimizing serum 25(OH)D levels to mitigate the risk of age-related ocular diseases: insights from a large-scale prospective cohort study |
| Journal: | Nutrition Journal |
| Published: | 31 May 2025 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/40450331/ |
| DOI: | https://doi.org/10.1186/s12937-025-01156-y |
| URL: | https://nutritionj.biomedcentral.com/counter/pdf/10.1186/s12937-025-01156-y |
Publication 15155
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
BackgroundInvestigations into the association between serum 25-hydroxyvitamin D (25(OH)D) levels and the risk of age-related ocular diseases have yielded inconsistent results. Thus, we aimed to provide robust longitudinal evidence, identify optimal serum thresholds, and explore the underlying mechanisms.MethodsWe analyzed data of 322,953 participants from the UK Biobank. The serum 25(OH)D levels were assessed using chemiluminescent immunoassay. Outcomes were incidences of cataract, primary open-angle glaucoma (POAG), age-related macular degeneration (AMD), and diabetic retinopathy (DR). Hazard ratios and 95% confidence intervals were estimated using Cox proportional hazards models. Nonlinear relationships were explored using restricted cubic splines, and mediation analyses were performed to delineate potential mechanistic pathways.ResultsOur findings revealed U-shaped associations for cataract and AMD, and L-shaped associations for DR (all P < 0.05), with an optimal threshold of approximately 50 nmol/L, while no association with POAG was observed. Below this threshold, each 10 nmol/L increase in serum 25(OH)D concentration was linked to a 3.5%, 4.2%, and 6.0% reduction in the risk of cataract, AMD, and DR, respectively (HR 0.965 [95% CI 0.951-0.980]; HR 0.958 [95% CI 0.921-0.997]; HR 0.940 [95% CI 0.894-0.989], respectively), while above 50 nmol/L, no significant protective effects were observed. Mediation analyses revealed that the low-grade inflammation score and triglyceride-glucose index may mediate the effects of serum 25(OH)D on cataract and DR.ConclusionsThis study identified 50 nmol/L as the optimal serum 25(OH)D threshold for reducing risks of cataract, AMD and DR, with no benefits beyond this level. The protective effects may be mediated through modulation of inflammation and glucolipid metabolism pathways. The threshold effects highlight the importance of targeted vitamin D supplementation under careful monitoring of serum levels to optimize ocular health outcomes.</p>
16 Keywords
- Aged
- Cataract
- Diabetic Retinopathy
- Eye Diseases
- Female
- Glaucoma, Open-Angle
- Humans
- Incidence
- Macular Degeneration
- Male
- Middle Aged
- Proportional Hazards Models
- Prospective Studies
- Risk Factors
- United Kingdom
- Vitamin D
6 Authors
- Zhiqian Huang
- Shuyu Liu
- Chao Chen
- Keke Zhang
- Yu Du
- Xiangjia Zhu
1 Application
| Application ID | Title |
|---|---|
| 93118 | Associations of lifestyle risk factors, ocular diseases, and mental disorders. |
Enabling scientific discoveries that improve human health